Literature DB >> 17218957

Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis.

K Meuer1, I E Suppanz, P Lingor, V Planchamp, B Göricke, L Fichtner, G H Braus, G P H Dietz, S Jakobs, M Bähr, J H Weishaupt.   

Abstract

Under physiological conditions, mitochondrial morphology dynamically shifts between a punctuate appearance and tubular networks. However, little is known about upstream signal transduction pathways that regulate mitochondrial morphology. We show that mitochondrial fission is a very early and kinetically invariant event during neuronal cell death, which causally contributes to cytochrome c release and neuronal apoptosis. Using a small molecule CDK5 inhibitor, as well as a dominant-negative CDK5 mutant and RNAi knockdown experiments, we identified CDK5 as an upstream signalling kinase that regulates mitochondrial fission during apoptosis of neurons. Vice versa, our study shows that mitochondrial fission is a modulator contributing to CDK5-mediated neurotoxicity. Thereby, we provide a link that allows integration of CDK5 into established neuronal apoptosis pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218957     DOI: 10.1038/sj.cdd.4402087

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  55 in total

Review 1.  Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease.

Authors:  Theodore J Wilson; Andrew M Slupe; Stefan Strack
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission.

Authors:  Hai-Ning Li; Mary Zimmerman; Gaolin Z Milledge; Xiao-Lin Hou; Jiang Cheng; Zhen-Hai Wang; P Andy Li
Journal:  Neurochem Res       Date:  2017-02-11       Impact factor: 3.996

4.  Phosphoproteomic analysis of protein phosphorylation networks in Tetrahymena thermophila, a model single-celled organism.

Authors:  Miao Tian; Xiulan Chen; Qian Xiong; Jie Xiong; Chuanle Xiao; Feng Ge; Fuquan Yang; Wei Miao
Journal:  Mol Cell Proteomics       Date:  2013-11-07       Impact factor: 5.911

5.  CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death.

Authors:  Arezu Jahani-Asl; En Huang; Isabella Irrcher; Juliet Rashidian; Naotada Ishihara; Diane C Lagace; Ruth S Slack; David S Park
Journal:  Hum Mol Genet       Date:  2015-05-22       Impact factor: 6.150

6.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 7.  Mitochondrial fragmentation in neurodegeneration.

Authors:  Andrew B Knott; Guy Perkins; Robert Schwarzenbacher; Ella Bossy-Wetzel
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

8.  The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.

Authors:  Ossama Khalaf; Bruno Fauvet; Abid Oueslati; Igor Dikiy; Anne-Laure Mahul-Mellier; Francesco Simone Ruggeri; Martial K Mbefo; Filip Vercruysse; Giovanni Dietler; Seung-Jae Lee; David Eliezer; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

9.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.